Therapeutics MD
TXMD2.0600.48% ( -0.010 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Therapeutics MD(TXMD) the Revenue is 724 K (+84.22%);the EBIT is -206 K (+73.69%);the EPS is 0.0082 (+113.4%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B84.22%
----
----
EBIT
-0.00B73.69%
----
----
EPS
0.0082113.35%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf